CHICAGO, IL USA (UroToday.com) - Bedwetting, or nocturnal enuresis (NE), is a widespread and distressing condition that impacts a child’s/young person's behavior and his/her emotional or social life. Although the enuresis alarm is the reported treatment choice in children with NE, there really is no distinction made between the body-worn alarm and the bell and pad alarms in terms of their effectiveness. The objective of this study was to collect information from clinical records in hospitals, incontinence clinics, and private practice on the success of bedwetting treatment practices in children using the bell and pad treatment.
The poster presented interim results of records of children with NE. The primary outcome was dryness for 14 consecutive nights, a measure based on the ICCS guidelines. The secondary outcome measure was determination of relapse rates as defined by more than two wet nights in two weeks after initial success (average number of wet nights after treatment had ceased). Study duration was 12 to 24 months and 3 000 clinical records were reviewed. The population was male (n=94, 62.6%) or female (n=56, 37.4%), healthy, developmentally normal children, between the ages of 6 and 15 who had no chronic medical conditions, no structural neurological bladder disorders, and had been treated for NE using a bell and pad alarm treatment system. Nine percent of the children had intellectual disability, 5% had autism spectrum disorder, and 2% had attention deficit disorder.
Results provided evidence of the bell and pad treatment and will be the basis for up-to-date guidelines and practical tools on the use of the bell and pad treatment. Based on the audit, the authors concluded that the bell and pad alarms are a valuable community resource to help with the treatment of children with bedwetting and should be first line of treatment for NE. This poster was awarded the first prize by the judges of this conference.
Presented by Esther Apos, Michelle Naughton, Shirley Whitaker, and Susie Gibb at the Simon Foundation for Continence's Innovating for Continence Conference Series - April 12 - 13, 2013 - Chicago, Illinois USA
Melbourne, Australia
Reported for UroToday.com by Diane K. Newman, DNP, ANP-BC, FAAN
About the Conference Series
The Innovating for Continence Conference Series is a unique, international, biennial conference for engineers, physicians, nurses, people with incontinence and their caregivers, academics, industry executives, and those with a passion for increased development of creative and efficacious products for the management of incontinence.
The multi-disciplinary meetings attract speakers from a wide range of disciplines and is organized and hosted by The Simon Foundation for Continence (Chicago, IL USA). It is made possible through generous support from individual and industry sponsors.
Professor Alan Cottenden is the ongoing chair for the conference series. He is Professor of Incontinence Technology at University College London, England. Professor Cottenden is the Chair of the Organizing Committee for the biennial conference "Incontinence: The Engineering Challenge" hosted by the UK Institution of Mechanical Engineers along with the committee on Management Using Continence Products of the International Consultation on Incontinence (ICI). He has been involved in continence technology for almost 30 years, working on clinical and basic science aspects as well as product development and international standards work (ISO).
